Publicaciones en colaboración con investigadores/as de Imperial College London (5)

2023

  1. Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI

    Cardiovascular Drugs and Therapy, Vol. 37, Núm. 5, pp. 941-953

  2. Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study

    The Lancet Regional Health - Europe, Vol. 31

2022

  1. Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 8, Núm. 4, pp. 447-460

2017

  1. Cost-effectiveness of evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular disease

    JAMA Cardiology, Vol. 2, Núm. 10, pp. 1069-1078

  2. Prediction of cardiovascular risk in patients with familial hypercholesterolaemia

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 3, Núm. 4, pp. 274-280